Parent Terms |
Term With Siblings |
Child Terms |
|
(13R)-13-dihydrocarminomycin
2'-deamino-2'-hydroxy-6'-dehydroparomamine
2'-deamino-2'-hydroxyneamine
2'-deamino-2'-hydroxyparomamine
2-deoxystreptamine 4-phosphate
21beta-hydroxyolean-12-en-3-one
4-\{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl\}-thiazol-2-yl-ammonium +
5-chloro-7-iodoquinolin-8-ol
6-desmethyl-N-methylfluvirucin A1
antiplatyhelmintic drug +
cefotiam hexetil dihydrochloride
ceftaroline fosamil acetate +
ceftaroline fosamil acetate monohydrate
ciprofloxacin dihydrochloride
ciprofloxacin hydrochloride (anhydrous) +
ciprofloxacin hydrochloride hydrate
demeclocycline hydrochloride
emetine dihydrochloride +
emetine dihydrochloride hydrate
metronidazole hydrochloride
moxifloxacin hydrochloride
mupirocin calcium (anhydrous) +
mupirocin calcium hydrate
N(3')-acetyl-2-deoxystreptamine antibiotic
paromomycin + An amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis.
silver(1+) sulfadiazinate
spectinomycin dihydrochloride
spectinomycin hydrochloride hydrate
|
|
|
Synonyms |
Related Synonyms: |
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside
;
Aminosidin
;
Catenulin
;
Formula=C23H45N5O14
;
Hydroxymycin
;
InChI=1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1
;
InChIKey=UOZODPSAJZTQNH-LSWIJEOBSA-N
;
Monomycin A
;
Paromomycin I
;
R-400
;
SMILES=NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O
;
Zygomycin A1
;
aminosidine
;
crestomycin
;
estomycin
;
neomycin E
;
paromomicina
;
paromomycine
;
paromomycinum
;
paucimycin
;
paucimycinum
|
Alternate IDs: |
CHEBI:44703
|
Xrefs: |
CAS:7542-37-2
;
DrugBank:DB01421
;
Drug_Central:2067
;
KEGG:C00832
;
KEGG:D07467
|
Xref Mesh: |
MESH:D010303
|
Xrefs: |
PDBeChem:PAR
;
PMID:18447603
;
PMID:18947845
;
PMID:8036682
;
Patent:US2895876
;
Patent:US2916485
;
Reaxys:72285 |
|